Past event: Biosensors for Medical Wearables USA Conference

We are proud to present the Biosensors for Medical Wearables Conference, taking place on the 24th - 25th October 2022.

The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and reliable physiological information allowing for better support of patient needs.

As part of our leading series of medical device conferences, this year's event will be exploring the key drivers and innovations of the wearable medical biosensors landscape with insights into the latest technologies uncovering the therapeutic scope of medical biosensors and the potential of wearable sensors for decentralized diagnostic testing. Furthermore, this year's conference will look at how industry is overcoming unmet needs including battery technologies and flexibility for wearable sensors. With growing digital application, the 2022 agenda will also assess the potential of Artificial Intelligence coupled with sensors and understand how industry is managing digital outcomes.

Day 1 will uncover the latest technologies advancing the therapeutic scope of biosensors and bringing medical grade wearables to the home featuring insights from BioIntellisense and MedRhythms, the potential of wearable sensors for decentralized diagnostic testing and a future outlook of the industry with case studies and discussions from Pfizer, Digital Medicine Society (DiMe) and the American Telemedicine Association (ATA).

Day 2 will take an in depth look at challenges and unmet needs of the industry including, battery technologies, regulatory compliance, flexible sensors and adhesives for advanced user-centric clinical grade measurement. With growing digital application, the 2022 agenda will also assess the potential of Artificial Intelligence coupled with sensors to managing digital outcomes and data with addresses from Beacon Biosignals and Biofourmis. Real-world examples will bring light to the importance of ensuring technical developments of wearable biosensors are bringing optimal solutions for patients in a healthcare setting.

Benefits of Attending

  • Explore the latest in biosensor technologies for wearable medical devices for therapeutics applications
  • Uncover the potential of wearable sensors for decentralized diagnostic testing
  • Delve into the evolving research and technologies to overcome unmet needs of the field including flexible sensors and regulatory updates
  • Assess the growing opportunities and sensor technologies being developed in industry for digital medicine and therapeutics through interactive panel discussions
  • Engage in platforms and opportunities for sensors coupled with AI and understand how industry are managing digital outcomes

Who should attend

Executives, Directors, VPs, Heads, Principals, Managers of:
  • Digital health and connectivity
  • Smart device developers
  • Device manufacturers
  • Biosensors
  • Wearable devices
  • Connected Devices
  • Microneedle Patches
  • Human Factors
  • Packaging
  • Regulatory Affairs
  • Medical Device Data

Speakers

  • Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe)
  • Carrie Northcott, Director and Project Lead, Pfizer Inc
  • Christine Guo, Chief Scientific Officer, ActiGraph
  • Eric Richardson, Vice President, MedRhythms
  • Greg Schulte, VP of Hardware, CALA
  • Jacob Donoghue, CEO and Co-Founder, Beacon Biosignals
  • James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
  • Jasmin Imsirovic, Associate Director, Takeda
  • Jaydev Thakkar, COO, Biofourmis
  • Jennifer Goldsack, CEO, Digital Medicine Society
  • Johannes Kreuzer, CEO, Cosinuss
  • John Ralston, CEO and Founder, Neursantys, Inc.
  • Jordan Brayanov, Head, Digital Strategy, Takeda Pharmaceuticals
  • Kate Gunning, Managing Partner, Focus Academy
  • Katie Chowdhury, Director, Regulatory Affairs, Digital & Medical Device Team, AbbVie
  • Krupal Patel, Assistant Member, Head & Neck - Endocrine, Moffitt Cancer Center
  • Pierre-Alexandre Fournier, Co-founder/CEO, Hexoskin
  • Prashant Kumar, CEO, TechBlocks Inc
  • Richard Bolander, Senior Wearable Design Engineer, TracPatch Health
  • Samir Shah, Director, AstraZeneca
  • Sherrie Trigg, Director of Medical Content and Editor-in-Chief, Medical Design Briefs
  • Shruti Iyer, Principal Innovation Architect, Oracle Health Sciences
  • Tero-Pekka Alastalo, Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
  • Xina Quan, Co-founder and CEO, PyrAmes, Inc

Please fill in your name and email to receive the Conference Agenda of this event.

Venue

Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA


Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-23750